Comparison Chart Spyre Therapeutics, Inc. Deutsche Boerse AG
Stocks
3920
US00773J2024
Biotechnology & Medical Research
|
Market Closed -
Deutsche Boerse AG
02:09:06 2026-09-04 EDT
|
5-day change | 1st Jan Change | ||
| 74.00 EUR | 0.00% |
|
-6.33% | +170.07% |
| 09-04 | Spyre Therapeutics Insider Sold Shares Worth $2,480,529, According to a Recent SEC Filing | MT |
| 09-04 | Spyre Therapeutics Insider Sold Shares Worth $1,309,410, According to a Recent SEC Filing | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | Bio Therapeutic Drugs | 0.00% | -6.33% | +170.07% | +413.89% | - | 7.85B |
-
|
-
|
-
|
- Stock Market
- Stocks
- SYRE Stock
- 3920 Stock
- Charts Spyre Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
